We used the A431 (vulval carcinoma, expressing ∼2 × 106 EGF receptors per cell [18]) and MDA-MB-468 (breast cancer, similar EGFR expression and EGFR responsiveness to A-431 cells [19]), both non-engineered cell lines. The gene discussed is EGFR; the disease is breast carcinoma.